Research is forever continuing, here in Australia and Overseas. 

Professor Allan Bretag, a Board Member for MDASA  has given us his annual research report below.

Alan Bretag – Research Report

 *****NEWS FLASH*****

BREAKING NEWS: FDA Approves Sarepta’s Exondys 51 (Eteplirsen) as First Therapy for Duchenne MD

Useful Research Websites 

The Australasian Neuromuscular Network Research 

Australian Clinical Trials 

Muscular Dystrophy Foundation Australia

Treat NMD

Muscular Dystrophy Association USA 

Medline Plus